Nasopharyngeal Aspirate
N/A
N/A
Keep specimen at 4C
N/A
Respiratory specimen of choice is a NASOPHARYNGEAL ASPIRATE. Collect the aspirate in a leukens trap and immediately transport to Clinical Virology Laboratory. Refer to the Nursing Procedure Manual, Section VII, Respiratory Care, 7:14:a for complete instructions on the collection of a nasopharyngeal aspirate using a leukens trap. Nasal washings, tracheal aspirates, and bronchoalveolar lavage specimens may be submitted. Collection of COMBINED THROAT AND NASOPHARYNGEAL SWABS is recommended for patients in which aspirates or washings cannot be readily obtained. For collection of nasopharyngeal swab specimen: 1. Insert swab into one nostril. 2. Press swab tip on the mucosal surface of the mid-inferior portion of the inferior turbinate, and rub the swab tip several times across the mucosal surface to loosen and collect cellular material. 3. Withdraw the swab; place swab into tube of Viral Transport Medium. For collection of oropharyngeal swab specimen: 1. Ask patient to open mouth widely and phonate an 'ah'. 2. Gently depress the tongue with a tongue blade. 3. Guide a swab over the tongue into the posterior oropharynx. 4. Using a gentle back-and-forth sweeping motion, swab the area behind the uvula and between the tonsillar pillars. 5. Withdraw the swab; place swab into the same tube of Viral Transport Medium that contains the nasoparyngeal swab. Immediately transport to the Clinical Virology Laboratory. If an extended delay in transport of specimens is anticipated, rapidly freeze the specimens to at least -60°C and transport to the laboratory on dry ice. Please consult the laboratory if necessary.
Swab specimens not received in viral transport medium or received in bacteriological transport medium are discouraged. DO NOT USE CALCIUM ALGINATE OR WOODEN SHAFT SWABS FOR COLLECTION OF SPECIMENS; ONLY USE DACRON OR RAYON TIPPED SWABS ON PLASTIC OR METAL SHAFTS.
Daily
Same day
N/A
87299
Indirect immunofluorescence assay using primary monoclonal antibodies specific for measles antigens and secondary fluorescein-labeled monoclonal antibodies.
If positive, results are reported as measles (rubeola) virus antigen detected.
Negative or no measles (rubeola) virus antigen detected
Clinical Utility: Measles (rubeola) is an acute illness that begins with a prodrome of cough, coryza, conjunctivitis. Patients will have an ascending (stepwise) fever to 39.5C. Koplik's spots (enanthem) may be observed on the inside of the mouth opposite the molar teeth. Skin rash (exanthem) occurs within 2 to 4 days of the prodrome and lasts 6 to 7 days. Initially erythematous and maculopapular. Progresses to confluence over time. Illness is highly contagious from 1 to 2 days before symptoms (3 to 5 days before rash) to 4 days after rash develops. Complications include otitis media, bronchopneumonia, croup, diarrhea, acute encephalitis, and subacute sclerosing panencephalitis (SSPE). Risk factors include age (<2 yrs and adults), nutritional status (malnourished), and immunocompromise. Characteristic rash may not develop in immunocommpromised patients. Measles is still a common and often fatal disease in developing countries, with an estimated 30 to 40 million cases and 745,000 deaths in 2001. Measles accounts for 48% of the 1.6 million deaths due to vaccine-preventable diseases occurring annually among children. Localized epidemics still seen in developed countries like the United States. Most cases are imported or linked to importation. Diagnosis of measles virus infection can be made by detection of virus-specific IgM and IgG antibody in serum, growth of the virus in culture from respiratory, eye, urine and whole blood specimens, and by rapid and direct detection of viral antigens in respiratory and eye specimens. At CHOP, it is recommended that a nasopharyngeal aspirate and conjunctival swab be submitted for rapid antigen detection and that serum be collected and submitted for measles-specific IgM and IgG serologies.